| JYHB2000371 | 盐酸普拉克索片 | pramipexole dihydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-04-11 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-07-29 | view |
| JYHB2000373 | 盐酸普拉克索片 | pramipexole dihydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-04-10 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-07-28 | view |
| JYHB2000374 | 盐酸普拉克索片 | pramipexole dihydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-04-02 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-07-28 | view |
| JYHB2000372 | 盐酸普拉克索片 | pramipexole dihydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-04-11 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-07-28 | view |
| JXHS1900155 | 利格列汀片 | linagliptin | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-12-09 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;West-Ward Columbus Inc | Certificate Issued | 2021-03-05 | view |
| JYHB2100110 | 利格列汀片 | linagliptin | Tablet | Chemical Drugs | Supplementary Application | 2021-02-03 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;West-Ward Columbus Inc | In Review | 2021-02-02 | view |
| JYHB2100070 | 利格列汀二甲双胍片(Ⅱ) | linagliptin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-01-19 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2021-02-01 | view |
| JXHL2100018 | BI685509片 | avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-19 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-18 | view |
| JXHL2100019 | BI685509片 | avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-19 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-18 | view |
| JXHL2100020 | BI685509片 | avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-19 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-18 | view |
| JXHL2100015 | BI 425809 片 | iclepertin | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-16 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-15 | view |
| JYHB2002594 | 二甲双胍恩格列净片（Ⅵ） | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-12-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-01-08 | view |
| JYHB2002593 | 二甲双胍恩格列净片（Ⅴ） | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-12-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-01-08 | view |
| JXHL2000357 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-04 | view |
| JXHL2000356 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-04 | view |
| JXHL2000360 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-04 | view |
| JXHL2000359 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-04 | view |
| JXHL2000358 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | In Review | 2021-01-04 | view |
| JYHB2002711 | 利格列汀二甲双胍片(Ⅱ) | linagliptin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-12-29 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Dragenopharm Apotheker Püschl GmbH | In Review | 2020-12-29 | view |
| JYHB2002710 | 利格列汀二甲双胍片(Ⅱ) | linagliptin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-12-29 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Dragenopharm Apotheker Püschl GmbH | In Review | 2020-12-29 | view |
